Neil Mason

517 total citations · 1 hit paper
14 papers, 263 citations indexed

About

Neil Mason is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Neil Mason has authored 14 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Neil Mason's work include Pancreatic and Hepatic Oncology Research (3 papers), Economic and Financial Impacts of Cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Neil Mason is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Economic and Financial Impacts of Cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Neil Mason collaborates with scholars based in United States and United Kingdom. Neil Mason's co-authors include Simon Swift, Simon Jones, Chris Moulton, Richard Oakley, Paul Molyneux, Steve Black, Clifford Mann, J. Kevin Hicks, Gillian C. Bell and Angelika Erwin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Neil Mason

13 papers receiving 253 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association between delays to patient admission from the emergency department and all-cause 30-day mortality

2022 102 citations Simon Jones, Chris Moulton et al. Emergency Medicine Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neil Mason United States	7	75	51	49	47	47	14	263
Fleur T. van de Wetering Netherlands	6	56 0.7×	51 1.0×	38 0.8×	35 0.7×	8 0.2×	11	289
Jack Sariego United States	12	44 0.6×	139 2.7×	50 1.0×	22 0.5×	80 1.7×	17	367
Rachel Ceccarelli United States	5	30 0.4×	19 0.4×	9 0.2×	23 0.5×	22 0.5×	8	222
Simona Cammarota Italy	10	26 0.3×	57 1.1×	11 0.2×	42 0.9×	57 1.2×	28	395
Forster Amponsah‐Manu United States	9	31 0.4×	95 1.9×	18 0.4×	25 0.5×	25 0.5×	19	265
Atul Juneja India	10	30 0.4×	56 1.1×	17 0.3×	45 1.0×	9 0.2×	28	303
Conan J O O’Brien United States	7	40 0.5×	78 1.5×	8 0.2×	39 0.8×	24 0.5×	9	301
Ali Rahimi Iran	9	20 0.3×	104 2.0×	44 0.9×	72 1.5×	13 0.3×	25	445
Ani Kardashian United States	14	20 0.3×	34 0.7×	44 0.9×	14 0.3×	46 1.0×	30	560
Randall W. Knoebel United States	12	9 0.1×	59 1.2×	30 0.6×	30 0.6×	10 0.2×	35	315

Countries citing papers authored by Neil Mason

Since Specialization

Citations

This map shows the geographic impact of Neil Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Mason more than expected).

Fields of papers citing papers by Neil Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Mason. The network helps show where Neil Mason may publish in the future.

Co-authorship network of co-authors of Neil Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Mason. A scholar is included among the top collaborators of Neil Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Mason. Neil Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Mason, Neil, Jacob J. Adashek, Youngchul Kim, et al.. (2023). Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. European Urology Oncology. 6(3). 331–338. 6 indexed citations

Jones, Simon, Chris Moulton, Simon Swift, et al.. (2022). Association between delays to patient admission from the emergency department and all-cause 30-day mortality. Emergency Medicine Journal. 39(3). 168–173. 102 indexed citations breakdown →

Fridley, Brooke L., et al.. (2022). Pilot Study in Investigating Material Financial Toxicity Markers by Age in Cancer Patients. Journal of Adolescent and Young Adult Oncology. 12(1). 34–42. 1 indexed citations

Sturgess, Richard, et al.. (2022). ERCP for bile duct stones across a national service, demonstrating a high requirement for repeat procedures. SHILAP Revista de lepidopterología. 11(2). E142–E148. 6 indexed citations

Mason, Neil, Y. Kim, Jacob J. Adashek, et al.. (2021). 667P Cost effectiveness of immune checkpoint inhibitors in combination with targeted therapies in metastatic renal cell carcinoma. Annals of Oncology. 32. S692–S692. 1 indexed citations

Jones, Simon, Neil Mason, Tom Palser, et al.. (2021). Trends in Risk‐Adjusted 28‐Day Mortality Rates for Patients Hospitalized with COVID‐19 in England. Journal of Hospital Medicine. 16(5). 290–293. 17 indexed citations

Mason, Neil, Julio M. Pow‐Sang, Robert A. Gatenby, et al.. (2021). Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer.. PubMed. 14(1). 15–20. 10 indexed citations

Hockings, Jennifer, Amy L. Pasternak, Angelika Erwin, et al.. (2020). Pharmacogenomics: An evolving clinical tool for precision medicine. Cleveland Clinic Journal of Medicine. 87(2). 91–99. 39 indexed citations

Mason, Neil, Julio M. Pow‐Sang, Robert A. Gatenby, et al.. (2019). Economic benefits of adaptive abiraterone therapy for advanced prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). e18343–e18343. 1 indexed citations

10.

Knepper, Todd C., Gillian C. Bell, J. Kevin Hicks, et al.. (2017). Key Lessons Learned from Moffitt’s Molecular Tumor Board: The Clinical Genomics Action Committee Experience. The Oncologist. 22(2). 144–151. 49 indexed citations

11.

Mason, Neil, Nikhil I. Khushalani, Jeffrey S. Weber, Scott Antonia, & Howard L. McLeod. (2016). Modeling the cost of immune checkpoint inhibitor-related toxicities.. Journal of Clinical Oncology. 34(15_suppl). 6627–6627. 11 indexed citations

12.

Mason, Neil, et al.. (2015). Budget impact analysis ofCYP2C19-guided voriconazole prophylaxis in AML. Journal of Antimicrobial Chemotherapy. 70(11). 3124–3126. 14 indexed citations

13.

Mason, Neil, Gillian C. Bell, & Howard L. McLeod. (2014). Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States. Value in Health. 17(7). A621–A622.

14.

Karandikar, Umesh C., et al.. (2003). The Drosophila SSL gene is expressed in larvae, pupae, and adults, exhibits sexual dimorphism, and mimics properties of the β subunit of casein kinase II. Biochemical and Biophysical Research Communications. 301(4). 941–947. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact